Call: +7 771 977 66 65, +7 705 421 2277
Sign in or Register
My basket

Astana Biomed Group, an authorized Abcam distributor in Central Asia

Abiomed homepage

  • Categories
    Signal Transduction
    Cancer
    Epigenetics and Nuclear Signaling
    Immunology
    Cell Biology
    Cardiovascular
    Neuroscience
    Tags & Cell Markers
    Kits/ Lysates/ Other
    Developmental Biology
    Microbiology
    Biochemicals
    Secondary antibodies
    Isotype/Loading Controls
    Antibody Arrays
  • About us
  • Partners
  • Contact
    Address

    Saryarka 32, 18, 010000, Astana city, Kazakhstan

    Telephone +7 771 977 66 65, +7 705 421 2277

    Email

    laboratory@ctlab.kz, orders@abiomed.kz

Back to category
Neuroscience Neurology process Neurodegenerative disease Parkinson's disease Synuclein

Human SNCA (Alpha-synuclein) knockout HEK293T cell pellet (ab278930)

Price and availability

670 ₸

Availability

Order now and get it on Tuesday March 09, 2021

Human SNCA (Alpha-synuclein) knockout HEK293T cell pellet (ab278930)
  • ChIP - Anti-Histone H3 antibody - Nuclear Loading Control and ChIP Grade (ab1791)
  • ChIP - Anti-Histone H3 antibody - Nuclear Loading Control and ChIP Grade (ab1791)

You may also be interested in

Product image
PE Anti-Alpha-synuclein antibody [MJFR1] (ab209306)
Product image
Recombinant human LRRK2 (mutated R1441C) protein (Active) (ab268736)
Product image
Anti-LRRK2 (phospho T2483) antibody [MJF-R8 (21-2e)] - BSA and Azide free (ab249271)
Product image
Anti-LRRK2 (phospho S1292) antibody [MJFR-19-7-8] - Low endotoxin, Azide free (ab206035)

Properties

  • Storage instructions

    Store at -80°C. Please refer to protocols.
  • Components 1 kit
    Human SNCA knockout HEK293T cell pellet 1 vial
    Human wild-type HEK293T cell pellet 1 vial
  • Research areas

    • Neuroscience
    • Neurology process
    • Neurodegenerative disease
    • Parkinson's disease
    • Synuclein
    • Neuroscience
    • Neurology process
    • Neurodegenerative disease
    • Alzheimer's disease
    • Tangles & Tau
  • Cell type

    epithelial
  • STR Analysis

    Amelogenin X D5S818: 8, 9 D13S317: 12, 14 D7S820: 11 D16S539: 9, 13 vWA: 16, 19 TH01: 7, 9.3 TPOX: 11 CSF1PO: 11, 12

Images

  • Western blot - Human SNCA (Alpha-synuclein) knockout HEK293T cell pellet (ab278930)
    Western blot - Human SNCA (Alpha-synuclein) knockout HEK293T cell pellet (ab278930)

    Lane 1: Wild-type HEK-293T cell lysate (20ug)
    Lane 2: SNCA knockout HEK-293T cell lysate (20ug)

    Lanes 1- 2: Merged signal (red and green). Green - ab138501 observed at 18 kDa. Red - loading control ab8245 observed at 37 kDa.

    ab138501 Recombinant Anti-Alpha-synuclein antibody [MJFR1] was shown to specifically react with SNCA in wild-type HEK-293T cells in western blot. Loss of signal was observed when knockout cell line ab255433 (knockout cell lysate ab263769) was used. Wild-type and SNCA knockout samples were subjected to SDS-PAGE. Membrane was blocked for 1 hour at room temperature in 0.1% TBST with 3% non-fat dried milk. ab138501 and Anti-GAPDH antibody [6C5] - Loading Control (ab8245) were incubated overnight at 4oC at 1 in 10000  and 1 in 20000 dilution respectively. Blots were developed with Goat anti-Rabbit IgG H&L (IRDye® 800CW) preadsorbed (ab216773) and Goat anti-Mouse IgG H&L (IRDye® 680RD) preadsorbed (ab216776) secondary antibodies at 1 in 20000 dilution for 1 hour at room temperature before imaging.

  • Sanger Sequencing - Human SNCA (Alpha-synuclein) knockout HEK293T cell pellet (ab278930)
    Sanger Sequencing - Human SNCA (Alpha-synuclein) knockout HEK293T cell pellet (ab278930)

    Allele-1: Insertion of the selection cassette in exon2; Allele-2: 1 bp insertion in exon2

     

Please note: All products are "FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC PROCEDURES"
For licensing inquiries, please contact partnerships@abcam.com

Clear all

Recently viewed products

  •  
  • Product image

    Human Survivin ELISA Kit (ab183361)

  •  
  • Product image

    Anti-TIMP4 antibody (ab58425)

Get resources and offers direct to your inbox Sign up
© 2021 Astana Biomed Group LLP. All rights reserved.